Showing results (1-10 of 109) with videos related to
Sort By:
Pageof 11
Critical Reviews in Immunology|January 7, 1998
HER-2/neu oncogenic protein: issues in vaccine developmentM L Disis, M A CheeverCurrent Opinion in Immunology|October 1, 1996
Oncogenic proteins as tumor antigensM L Disis, M A CheeverAdvances in Cancer Research|January 1, 1997
HER-2/neu protein: a target for antigen-specific immunotherapy of human cancerM L Disis, M A CheeverImmunology|June 9, 1998
Human HER-2/neu protein immunization circumvents tolerance to rat neu: a vaccine strategy for 'self' tumour antigensM L Disis, F M Shiota, M A CheeverBlood|August 15, 2000
Immunity to WT1 in the animal model and in patients with acute myeloid leukemiaA Gaiger, V Reese, M L Disis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccineM L Disis, K H Grabstein, P R Sleath, et al.Annals of the New York Academy of Sciences|August 12, 1993
T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-ablM A Cheever, W Chen, M L Disis, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Induction of T cells specific for the mutated segment of oncogenic P21ras protein by immunization in vivo with the oncogenic proteinD J Peace, J W Smith, M L Disis, et al.Cancer Research|February 15, 1994
In vitro generation of human cytolytic T-cells specific for peptides derived from the HER-2/neu protooncogene proteinM L Disis, J W Smith, A E Murphy, et al.Cancer Research|March 1, 1995
Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral bloodH Bernhard, M L Disis, S Heimfeld, et al.Pageof 11